Clinical Trial

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

Study acronym: PSOCADIA
Recruiting
View on ClinicalTrials.gov →
Summary
In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-07-02; most recent amendment 2025-09-09.
Status change: Not Yet Recruiting → Recruiting 2021-08-31
Trial Details
NCT Number NCT04950218
Lead Sponsor Herlev and Gentofte Hospital
Conditions Psoriasis, Cardiovascular Diseases, Cardiovascular Risk Factor, Cardiovascular Pathology, Psoriasis Vulgaris, Psoriatic Nail, Psoriasis Face, Psoriasis Guttate +16 more
Enrollment 1,000 participants
Start Date 2021-09-01
Primary Completion 2034-10-01 (estimated)
Study Completion 2034-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-15